BP 812 (Phenazopyridine hydrochloride 200 mg)
Pill imprint BP 812 has been identified as Phenazopyridine hydrochloride 200 mg.
Phenazopyridine is used in the treatment of interstitial cystitis; dysuria and belongs to the drug class miscellaneous genitourinary tract agents. There is no proven risk in humans during pregnancy. Phenazopyridine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- BP 812
- Strength:
- 200 mg
- Color:
- Brown
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Miscellaneous genitourinary tract agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Boca Pharmacal, Inc.
- National Drug Code (NDC):
- 64376-0812
- Inactive Ingredients:
- hypromelloses
mineral oil
magnesium stearate
povidone
croscarmellose sodium
microcrystalline cellulose
corn starch
silicon dioxide
Note: Inactive ingredients may vary.
More about phenazopyridine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 87 Reviews – Add your own review/rating
- Drug class: miscellaneous genitourinary tract agents
Consumer resources
Other brands: Pyridium, Azo Urinary Pain Relief, Uristat, Azo-Standard, More... (7)
Professional resources
- Phenazopyridine Hydrochloride (AHFS Monograph)
- Phenazopyridine Tablets (FDA)
- Phenazopyridine (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
